The Cigna Group
1.77xPrice / book
Market cap
$73.66B
Tangible equity (USD)
-$31.77B
Price / tangible book
—
Price / book
1.77x
Net income / ending equity
14.3%
Net income / ending assets
3.8%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $73.66B · View financials
Snapshot Sep 11, 2026, 11:55 AM ET
FY 2025 · Mkt cap
Decision snapshot: CI stock price at premium vs SYF $278.78 current versus $180.71 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SYF's multiple
Implied fair value · at CI's multiple
Snapshot Sep 11, 2026, 11:55 AM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Lower is better
Profitability lag
Asset efficiency edge
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$73.66B
Tangible equity (USD)
-$31.77B
Price / tangible book
—
Price / book
1.77x
Net income / ending equity
14.3%
Net income / ending assets
3.8%
Efficiency ratio
—
Price / book
Market cap
$24.60B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
1.47x
Net income / ending equity
21.2%
Net income / ending assets
3.0%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The Cigna Group · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Synchrony Financial · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNITEDHEALTH GROUP INC
CI vs UNH
CVS HEALTH Corp
CI vs CVS
HUMANA INC
CI vs HUM
CENTENE CORP
CI vs CNC
WEST PHARMACEUTICAL SERVICES INC
CI vs WST
BAXTER INTERNATIONAL INC
CI vs BAX
CAPITAL ONE FINANCIAL CORP
CI vs COF
American Express Company
CI vs AXP
JPMorgan Chase & Co.
CI vs JPM
Citigroup Inc.
CI vs C
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.